Counterpoint: The vision for a new diagnostic paradigm.
Petricoin
Emanuel
E
NCI-FDA Clinical Proteomics Program, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
Liotta
Lance A
LA
D015415:Biomarkers / Q000097:blood; D019411:Clinical Laboratory Techniques / Q000592:standards*; D006801:Humans; D007753:Laboratories / Q000592:standards; D013058:Mass Spectrometry; D011506:Proteins / Q000032:analysis*; D040901:Proteomics; D012680:Sensitivity and Specificity
D015415:Biomarkers; D011506:Proteins